Fludarabine phosphate

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

2297 clinical trials

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Leukemia	D007938	—	C95	404	545	99	16	59	948
Lymphoma	D008223	—	C85.9	278	315	36	3	38	571
Myeloid leukemia acute	D015470	—	C92.0	177	245	57	6	26	440
Myeloid leukemia	D007951	—	C92	166	242	46	5	24	411
Lymphoid leukemia	D007945	—	C91	178	217	42	7	21	394
Myelodysplastic syndromes	D009190	—	D46	124	258	25	2	29	384
Precursor cell lymphoblastic leukemia-lymphoma	D054198	—	C91.0	175	191	19	5	24	350
B-cell chronic lymphocytic leukemia	D015451	—	C91.1	119	181	36	3	15	306
Non-hodgkin lymphoma	D008228	—	C85.9	155	161	16	1	21	295
Preleukemia	D011289	—	—	91	178	14	2	19	266

Show 13 more

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Neoplasms	D009369	—	C80	185	143	5	—	16	294
Hematologic neoplasms	D019337	—	—	77	117	4	—	19	186
Plasma cell neoplasms	D054219	—	—	92	76	9	—	16	173
Bcr-abl positive chronic myelogenous leukemia	D015464	EFO_0000340	—	33	111	7	—	11	142
Hodgkin disease	D006689	—	C81	46	82	3	—	13	124
Melanoma	D008545	—	—	55	63	2	—	2	104
Follicular lymphoma	D008224	—	C82	38	55	12	—	5	99
Mantle-cell lymphoma	D020522	—	C83.1	41	53	9	—	6	93
Anemia	D000740	EFO_0004272	D64.9	26	62	10	—	12	88
Myelomonocytic leukemia juvenile	D054429	—	C93.3	28	49	1	—	6	72

Show 47 more

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Carcinoma	D002277	—	C80.0	59	27	—	—	4	72
Ovarian neoplasms	D010051	EFO_0003893	C56	46	22	—	—	—	56
T-cell lymphoma	D016399	—	—	26	33	—	—	5	56
Plasmacytoma	D010954	—	C90.3	14	30	—	—	9	49
Breast neoplasms	D001943	EFO_0003869	C50	34	25	—	—	—	46
Renal cell carcinoma	D002292	EFO_0000376	—	28	22	—	—	3	42
Precursor t-cell lymphoblastic leukemia-lymphoma	D054218	—	—	36	16	—	—	—	39
Hematologic diseases	D006402	EFO_0005803	D75.9	10	21	—	—	9	37
T-cell lymphoma peripheral	D016411	—	—	17	20	—	—	4	35
Non-small-cell lung carcinoma	D002289	—	—	27	15	—	—	—	34

Show 274 more

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Rhabdoid tumor	D018335	—	—	4	—	—	—	—	4
Female genital neoplasms	D005833	—	—	4	—	—	—	—	4
Small cell lung carcinoma	D055752	—	—	3	—	—	—	—	3
Wilms tumor	D009396	EFO_0000212	—	3	—	—	—	—	3
Nervous system diseases	D009422	—	G00-G99	3	—	—	—	—	3
Autoimmune diseases of the nervous system	D020274	—	—	3	—	—	—	—	3
Chronic progressive multiple sclerosis	D020528	EFO_0003840	—	3	—	—	—	—	3
Ependymoma	D004806	—	—	2	—	—	—	—	2
Gastrointestinal stromal tumors	D046152	EFO_0000505	C49.A	2	—	—	—	—	2
Adrenocortical carcinoma	D018268	—	—	2	—	—	—	—	2

Show 57 more

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Abnormal karyotype	D059786	—	—	—	—	—	—	1	1
Hemoglobin c disease	D006445	—	D58.2	—	—	—	—	1	1
Mucositis	D052016	EFO_1001898	—	—	—	—	—	1	1
Type 1 hyper-igm immunodeficiency syndrome	D053307	—	—	—	—	—	—	1	1
Hereditary congenital and neonatal diseases and abnormalities	D009358	—	—	—	—	—	—	1	1
Primary graft dysfunction	D055031	—	—	—	—	—	—	1	1
Antiphospholipid syndrome	D016736	EFO_0002689	D68.61	—	—	—	—	1	1
Alveolar soft part sarcoma	D018234	—	—	—	—	—	—	1	1